I've had my eye on this one for a little while. I follow biotech/biomed quite a bit. Without the pending buyout at $,27 this would probably trading well over $1. Maybe the board will perform their fiduciary duty and blow off the sale.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.